Medicare recently launched a new program called the Medicare Part D Senior Savings Model Program to test the impact of giving Medicare beneficiaries 65 and older an increased choice of Part D plans with no deductible and a max copay of $35 per month for insulin and fixed-ratio combination GLP-1 RAs Soliqua and Xultophy.
read more →
The FDA recently approved Wegovy, the first and only once-weekly injection for chronic weight management in adults.
read more →
Dr. Edelman clarifies how SGLTs and GLP-1s affect insulin use, and whether or not they cause hypoglycemia.
read more →
Our international panel of diabetes experts discussed highlights from the ADA’s Scientific Sessions, and lead a Q&A on some of the most important advances in diabetes.
read more →
GLP-1 RAs like Ozempic, Rybelsus, Bydureon and Trulicity are primarily used to control blood sugar in people with type 2 diabetes, but these medications have some important additional benefits, including new designations at higher doses for weight loss.
read more →
If You’re a Member of the Healthcare Community–You Can’t Miss Our Next CME!
Earn easy CME credits and improve patient outcomes—all at your own pace.
